The Kingdom of Eswatini has been recognized and applauded by Medicines for Africa for meeting and exceeding the global 95-95-95 Ending AIDS targets and is the first country in Africa to have achieved this phenomenal milestone. Medicines for Africa is an organization that provides data-driven strategic sourcing of quality medicines from reputable manufacturers, Medicines for Africa consolidates demand to create economies of scale and coordinate joint purchasing in order to reduce the cost of quality medicines.
The global 95-95-95 target means that 95% of people living with HIV in Eswatini know their status, that 95% of those who know their HIV positive status are accessing treatment and that 95% of people on treatment have suppressed viral load. This means, an entire generation of children are likely to be born HIV free because of wide treatment coverage. This shows how great progress is made when governments commit to investing in the health of their people.
Even so, Eswatini, together with Switzerland, are the first countries to achieve the ‘95-95-95’ global HIV target. For Eswatini, this success can be attributed to the robust investment in HIV prevention and treatment interventions targeting the hardest-to-reach and most vulnerable populations. These interventions include girls and young women, who are not only the most affected population in the Kingdom but across East and southern Africa continue to be disproportionately affected by HIV. In Eswatini, 63% of people living with HIV are women. Adolescent girls and young women take part in safe sex training, facilitated by PACT (please define acronyms first for the benefit of the general person not knowledgeable in the field), where they are taught about relationships, safe sex, HIV prevention, gender and strategies for those living with HIV.